ID KCRT_ONCMY Reviewed; 383 AA. AC P24722; DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-1992, sequence version 1. DT 02-SEP-2026, entry version 94. DE RecName: Full=Creatine kinase, testis isozyme; DE EC=2.7.3.2; GN Name=tck1; OS Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii; Salmoniformes; OC Salmonidae; Salmoninae; Oncorhynchus. OX NCBI_TaxID=8022; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Testis; RX PubMed=2223887; DOI=10.1016/0167-4781(90)90215-n; RA Garber A.T., Winkfein R.J., Dixon G.H.; RT "A novel creatine kinase cDNA whose transcript shows enhanced testicular RT expression."; RL Biochim. Biophys. Acta 1087:256-258(1990). CC -!- FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP CC and various phosphogens (e.g. creatine phosphate). Creatine kinase CC isoenzymes play a central role in energy transduction in tissues with CC large, fluctuating energy demands, such as skeletal muscle, heart, CC brain and spermatozoa. CC -!- CATALYTIC ACTIVITY: CC Reaction=creatine + ATP = N-phosphocreatine + ADP + H(+); CC Xref=Rhea:RHEA:17157, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:57947, ChEBI:CHEBI:58092, ChEBI:CHEBI:456216; EC=2.7.3.2; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10029}; CC -!- TISSUE SPECIFICITY: Exists in many tissues, but preferentially in CC testis. {ECO:0000269|PubMed:2223887}. CC -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family. CC {ECO:0000255|PROSITE-ProRule:PRU00842, ECO:0000255|PROSITE- CC ProRule:PRU00843}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X53859; CAA37852.1; -; mRNA. DR PIR; S13164; S13164. DR RefSeq; NP_001118187.1; NM_001124715.2. DR AlphaFoldDB; P24722; -. DR SMR; P24722; -. DR GeneID; 100136767; -. DR KEGG; omy:100136767; -. DR OrthoDB; 430219at2759; -. DR Proteomes; UP000694395; Unplaced. DR GO; GO:0004111; F:creatine kinase activity; IEA:UniProtKB-EC. DR GO; GO:0046314; P:phosphocreatine biosynthetic process; IEA:InterPro. DR CDD; cd00716; creatine_kinase_like; 1. DR FunFam; 3.30.590.10:FF:000026; Creatine kinase B-type; 1. DR FunFam; 1.10.135.10:FF:000001; Creatine kinase M-type; 1. DR Gene3D; 1.10.135.10; ATP:guanido phosphotransferase, N-terminal domain; 1. DR Gene3D; 3.30.590.10; Glutamine synthetase/guanido kinase, catalytic domain; 1. DR InterPro; IPR000749; ATP-guanido_PTrfase. DR InterPro; IPR022415; ATP-guanido_PTrfase_AS. DR InterPro; IPR022414; ATP-guanido_PTrfase_cat. DR InterPro; IPR022413; ATP-guanido_PTrfase_N. DR InterPro; IPR036802; ATP-guanido_PTrfase_N_sf. DR InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom. DR PANTHER; PTHR11547; ARGININE OR CREATINE KINASE; 1. DR PANTHER; PTHR11547:SF23; CREATINE KINASE B-TYPE; 1. DR Pfam; PF00217; ATP-gua_Ptrans; 1. DR Pfam; PF02807; ATP-gua_PtransN; 1. DR SUPFAM; SSF55931; Glutamine synthetase/guanido kinase; 1. DR SUPFAM; SSF48034; Guanido kinase N-terminal domain; 1. DR PROSITE; PS00112; PHOSPHAGEN_KINASE; 1. DR PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1. DR PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1. PE 2: Evidence at transcript level; KW ATP-binding; Kinase; Nucleotide-binding; Reference proteome; Transferase. FT CHAIN 1..383 FT /note="Creatine kinase, testis isozyme" FT /id="PRO_0000211984" FT DOMAIN 14..100 FT /note="Phosphagen kinase N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00842" FT DOMAIN 127..369 FT /note="Phosphagen kinase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT REGION 99..119 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 99..112 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 130..134 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 193 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 238 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 294 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 322..327 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 337 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" SQ SEQUENCE 383 AA; 43004 MW; 608BAAA115C7D1EA CRC64; MEKINDKMAK LTIKRLSPEE EFPDLSQHNN HMAKVLTQDM YTKLRDRATP NGFTIDGVIQ TGIDNPGHPF IMTVGCVAGD EETYEVFKEL LDPIIEDRHG GYKPTDKHKT DLNPDNLKGG DDLDPNYVIS SRVRTGRSIR GFCLPPHCSR GERRGVEKMS VEALDSLSGD LKGKYYALKN MTDAEQQQLI DDHFLFDKPV SPLLLASGMA RDWPDGRGIW HNDTKTFLVW VNEEDHLRVI SMQKGGNMKE VFNRFCTGLT KIETLFKDKG TSFMWNEHLG YVLTCPSNLG TGLRAGVHVK IPNISKHAKF EEVLKRLRLQ KRGTGGVDTA AVGGTFDISN ADRLGFSEVE LVQMVVDGVK LLVEMEKKLE KGQSIDDLMP AQK //